Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The right combination of estrogen and a selective estrogen receptor modulator, which blocks the effects of estrogen in breast tissue, could relieve menopause symptoms and cut breast cancer risk, Yale researchers. Women in menopause who have symptoms, but have not had a hysterectomy are currently treated with a combination of estrogen plus progestin hormone therapy, but this treatment comes with side effects, including a higher risk of breast cancer caused by the progestin.

   

Today in Popular Press...keeping you current

Polymer therapeutic protects gut from radiation damage, infection after cancer treatment
EurekAlert, 12/04/09

Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit
ScienceDaily, 12/04/09

Exposure to Secondhand Cigarette Smoke Over a Lifetime Increased Breast Cancer Risk Later in Life
ScienceDaily, 12/04/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address